And José A. Giacometti - Infectious Diseases

Author Information

Andrea Giacometti is a renowned researcher in the field of Infectious Diseases. He is affiliated with the Department of Biological Sciences and Public Health at Marche Polytechnic University, located in Ancona, Italy. His work primarily focuses on the treatment and understanding of infections, with a significant emphasis on multidrug-resistant pathogens and novel therapeutic approaches.

Research Contributions

Andrea Giacometti has made substantial contributions to the field of infectious diseases, particularly in the study and treatment of multidrug-resistant pathogens and infections related to COVID-19. In recent years, his research has explored new therapies for bacterial infections, the efficacy of drugs like Ceftazidime–Avibactam, and the impact of COVID-19 on bloodstream infections. Notably, his work includes studies on the use of Dalbavancin in treating skin, bone, and joint infections, and the potential harms of glucocorticoid misuse during the early phase of SARS-CoV-2 infection.

Aliases

Andrea Giacometti is also known by several aliases including A Giacometti, A. Giacometti, and And José A. Giacometti. These variations have been used in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	310
Total Citations	8075
h-index	49

Publications:

Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study

DOI: 10.3390/antibiotics11030321

Year: 2022

Relationship of Blastocystis subtypes and its co-infection with other parasites to the infection symptoms

DOI:

Year: 2021

Tocilizumab in COVID‐19 interstitial pneumonia

DOI: 10.1111/joim.13231

Year: 2021

New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing

DOI: 10.3390/antibiotics10111377

Year: 2021

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center

DOI: 10.3390/antibiotics10091129

Year: 2021

Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study

DOI: 10.1016/j.ijid.2021.07.065

Year: 2021

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

DOI: 10.1097/QAI.0000000000002787

Year: 2021

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model

DOI: 10.3390/antibiotics10101210

Year: 2021

Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence

DOI: 10.1007/s11739-021-02860-3

Year: 2021

Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates.

DOI: 10.2217/fmb-2020-0204

Year: 2021

What are the Symptoms of Strep Throat?

What Role Do Respiratory Droplets Play in Super-Spreading Events?

What are the Symptoms of West Nile Virus?

How are Sporozoites Transmitted?

What are the Challenges in Controlling Schistosomiasis?

How Do Pathogens Exploit Host Metabolic Pathways?

How Can Technology Help?

What Role Does Technology Play in Eradication?

How Do Human Activities Amplify These Effects?

How Are Fungal Infections Treated?

Partnered Content Networks

Relevant Topics